Skip to main content

Table 1 Responses: cardiologists vs oncologists; p-values determined via chi-squared analysis

From: Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey

Survey Question

Cardiologists

Oncologists

P-value

Yes (n (%))

No (n (%))

Yes (n (%))

No (n (%))

Statistical significance < 0.05

“Does your institution provide proper protection for all health care workers to the level they are exposed?”

684 (70.6%)

285 (29.4%)

210 (69.3%)

93 (30.7%)

P = 0.598

“Have timely surgery/chemo/immunotherapy treatments for your patients been delayed since the COVID-19 pandemic started?”

498 (56.4%)

385 (43.6%)

152 (50%)

152 (50%)

P < 0.001

“Do you use telemedicine to reduce in-person encounters and health care providers’ exposure?”

818 (85.0%)

151 (15.0%)

269 (89.4%)

32 (10.6%)

P = 0.085

“Have you been asked to reduce your specialized practice to help/contribute to other areas where urgent help is needed?”

442 (45.5%)

529 (54.5%)

76 (25.2%)

226 (74.8%)

P < 0.001

“Have you had in service instruction/guidelines from leadership at your institution about policies to protect your patients, your team, your colleagues and yourself?”

839 (86.1%)

136 (13.9%)

272 (89.2%)

33 (10.8%)

P = 0.168

“Do you feel you have adequate support from your institution’s leadership to carry on with your duties?”

690 (71.5%)

275 (28.5%)

232 (76.1%)

73 (23.9%)

P = 0.030

“Do you discuss with all your patients the importance of strict adherence to COVID-19 community behavior as part of your office/clinic encounters?”

885 (91.5%)

82 (8.5%)

285 (95%)

15 (5%)

P = 0.141

“Do you have access to COVID-19 testing at your institution or local lab?”

730 (75.1%)

242 (24.9%)

205 (67.4%)

99 (32.6%)

P = 0.017

“Has your institution used Tocilizumab or other anti-inflammatory agents for COVID-19 related myocarditis?”

130 (15.1%)

733 (84.9%)

42 (16.7%)

210 (83.3%)

P = 0.059

Has your institution used empiric treatment with Remdesivir or other anti-viral treatments for the sickest patients?

289 (32.7%)

595 (67.3%)

69 (26.1%)

195 (73.9%)

P = 0.035

“In your opinion, should there be a government mandated nationwide quarantine/lock-down to slow down the propagation/transmission of COVID-19?”

826 (85.7%)

138 (14.3%)

259 (86.6%)

40 (13.4%)

P = 0.909

“Should medical professional organizations take a more active role, and have more influence in official health care policy decisions during this major crisis?”

926 (95.2%)

47 (4.8%

289 (95.7%)

13 (4.3%)

P = 0.931